Xtant Medical Holdings (XTNT) Revenue Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Xtant Medical Holdings | 64.46 Mn | 47.14 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 18.92% |
| Jun 30, 2025 | 27.54% |
| Mar 31, 2025 | 17.36% |
| Dec 31, 2024 | 13.41% |
| Sep 30, 2024 | 12.19% |
| Jun 30, 2024 | 14.53% |
| Mar 31, 2024 | 10.75% |
| Dec 31, 2023 | 8.63% |
| Sep 30, 2023 | 7.70% |
| Jun 30, 2023 | 1.64% |
| Mar 31, 2023 | 0.01% |
| Dec 31, 2022 | -11.10% |
| Sep 30, 2022 | -6.08% |
| Jun 30, 2022 | -6.49% |
| Mar 31, 2022 | -10.12% |
| Dec 31, 2021 | -10.97% |
| Sep 30, 2021 | -9.71% |
| Jun 30, 2021 | -6.81% |
| Mar 31, 2021 | -9.82% |
| Dec 31, 2020 | -8.84% |
| Sep 30, 2020 | -4.60% |
| Jun 30, 2020 | 1.19% |
| Mar 31, 2020 | 9.23% |
| Dec 31, 2019 | 11.80% |
| Sep 30, 2019 | 13.77% |
| Jun 30, 2019 | 11.76% |
| Mar 31, 2019 | 13.42% |
| Dec 31, 2018 | 16.54% |
| Sep 30, 2018 | 16.84% |
| Jun 30, 2018 | 17.88% |
| Mar 31, 2018 | 15.78% |
| Dec 31, 2017 | 28.06% |
| Sep 30, 2017 | 18.02% |
| Jun 30, 2017 | 21.37% |
| Mar 31, 2017 | 23.23% |
| Dec 31, 2016 | 22.37% |
| Sep 30, 2016 | 24.89% |
| Jun 30, 2016 | 23.66% |
| Mar 31, 2016 | 29.01% |
| Dec 31, 2015 | 34.35% |
| Sep 30, 2015 | 34.33% |
| Jun 30, 2015 | 25.31% |